Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and... see more

TSXV:VPT - Post Discussion

View:
Post by bluemoons20 on Sep 08, 2021 5:32pm

keep going!!

hit as high as  .51  today after settling back.  but still  reasonable volume  to keep  interest and  keep the price  up.

If the volume slips.  the price might too.

This recent spurt  is not likely  from  granting of options.

Anyone got any ideas  on underlying  events  not yet reported??

GLTA
Comment by pantonor on Sep 08, 2021 11:28pm
This post has been removed in accordance with Community Policy
Comment by jopatclo on Sep 09, 2021 8:42am
This post has been removed in accordance with Community Policy
Comment by ScienceFirst on Sep 09, 2021 8:44am
JoPatClo ... Can you provide the link to this GE whitepaper that you're referring to? _______________________ jopatclo - (9/9/2021 8:42:07 AM) RE:keep going!!  GE just recently published this whitepaper. Items 4-6, that's us, especially item 6. That's the KBR (Knowledge Based Recognition) VMS tech. Those are the MRI images from all over the world that VPT bought the ...more  
Comment by jopatclo on Sep 09, 2021 9:45am
This post has been removed in accordance with Community Policy
Comment by jopatclo on Sep 09, 2021 10:03am
This post has been removed in accordance with Community Policy
Comment by jopatclo on Sep 09, 2021 10:31am
This post has been removed in accordance with Community Policy
Comment by G1945V on Sep 09, 2021 4:30pm
jopatclo, what you have posted has nothing to do with what VPT does. What you posted is the GE Vivid E9 which they have had for some time now. G1945V  
Comment by jopatclo on Sep 09, 2021 8:44am
This post has been removed in accordance with Community Policy
Comment by GrahamB on Sep 09, 2021 9:36am
[/citation]   [/quote] Can you provide a reference to support your claim. From my reading, your statement is not accurate and not verifiable. GE has thier own dataset and have a rich dataset they have independently tested and are currently using. This has been previously referenced in several posts I made when doing my research in this area.
Comment by Pandora on Sep 11, 2021 8:26pm
A little off-topic but with similarities I found interesting from a technolgy point-of-view. Different study analysis but seems to have similar characteristics from a medical perspective of viewing a part of the human anatomy. This system is an imaging system associated with breast cancer and they use AI as an adjunct to the system. They also have 400 volumes of images that they use as a resource ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities